PuSH - Publication Server of Helmholtz Zentrum München

Kleine-Tebbe, J.* ; Zuberbier, T.* ; Werfel, T.* ; Krüll, M.* ; Wagenmann, M.* ; Johansen, N.* ; Adler Würtzen, P.* ; Wolf, H.* ; Mücke, V.* ; Wüstenberg, E.* ; Biedermann, T.

Is allergy immunotherapy with birch sufficient to treat patients allergic to pollen of tree species of the birch homologous group?

Allergy 75, 1327-1336 (2019)
Publ. Version/Full Text Postprint DOI
Open Access Green
Pollen from various Fagales tree species prolongs the season and makes tree pollen allergy a major health problem. Despite involving the same causative allergens, allergy immunotherapy (AIT) treatment habits differ significantly across different geographical regions. Diagnosis and treatment with AIT in patients allergic to tree pollen were discussed by a group of German medical experts who give practical recommendations based on the available data. Regulatory perspective: According to current guidelines on allergen products, birch pollen are the representative allergen source of the birch homologous group including several Fagales trees based on sequence and structural similarity of their allergen proteins. Immunological perspective: A high level of IgE cross-reactivity towards allergens from the birch homologous group has been observed in basic research and clinical trials. Clinical perspective: Clinical trial data show that the efficacy of birch pollen AIT is not only related to birch pollen allergy but extends to pollen from other trees, especially alder, hazel and oak. In order to optimize diagnosis and treatment of tree pollen allergy, the experts recommend to focus diagnosis and respective treatment with AIT primarily to birch as the representative allergen of the Fagales tree homologous group, but further diagnostics may be needed for some patients to determine adequate treatment.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Keywords Allergy Immunotherapy ; Birch Pollen Allergens ; Birch Homologous Group ; Tree Allergens ; Tree Pollen Allergy; Randomized Controlled-trial; Bet-v-i; Double-blind; Sublingual Immunotherapy; Clinical-efficacy; Cross-reactivity; Major Allergen; Inhibition; Antibody; Tablet
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Journal Allergy
Quellenangaben Volume: 75, Issue: 6, Pages: 1327-1336 Article Number: , Supplement: ,
Publisher Wiley
Publishing Place 111 River St, Hoboken 07030-5774, Nj Usa
Reviewing status Peer reviewed